We are live on
!
Find out more
RMCM
Reynders McVeigh Capital Management Portfolio holdings
AUM
$1.98B
1-Year Est. Return
23.37%
This Fund
S&P 500
This Quarter
Est. Return
+6.04%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$932M
AUM Growth
+$28.1M
(+3.1%)
Cap. Flow
-$18.5M
Cap. Flow
% of AUM
-1.98%
Top 10 Holdings %
Top 10 Hldgs %
34.27%
Holding
222
New
12
Increased
42
Reduced
117
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$3.47M |
| 2 |
American Eagle Outfitters
AEO
|
+$2.72M |
| 3 |
Becton Dickinson
BDX
|
+$2.05M |
| 4 |
RDFN
Redfin
RDFN
|
+$1.31M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$1.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$4.58M |
| 2 |
Mastercard
MA
|
+$2.99M |
| 3 |
Biogen
BIIB
|
+$2.95M |
| 4 |
Johnson & Johnson
JNJ
|
+$2.66M |
| 5 |
Autoliv
ALV
|
+$1.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.85% |
| 2 | Technology | 18.2% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 12.07% |
| 5 | Communication Services | 10.75% |
Similar funds
SC
CAM
TCM
RCM
LGM
MYAM
NIM
C
Reynders McVeigh Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Reynders McVeigh Capital Management held 222 positions worth $932M, up 3.1% from $904M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Reynders McVeigh Capital Management's Q2 2019 filing shows 12 new, 42 increased, 117 reduced and 9 closed positions. Its largest new stake was Alcon: 59,134 shares worth $3.67M. The largest sale was Novartis, an estimated $4.58M.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 28% a quarter earlier, followed by Technology and Financials.
- Reynders McVeigh Capital Management's largest Q2 2019 buy was Alcon: 59,134 shares worth $3.67M.
- Reynders McVeigh Capital Management added most to American Eagle Outfitters in Q2 2019, an estimated $2.72M increase.
- Reynders McVeigh Capital Management's biggest Q2 2019 reduction was Novartis, cutting an estimated $4.58M.
- Reynders McVeigh Capital Management fully exited Autoliv in Q2 2019, selling an estimated $1.32M.
- Reynders McVeigh Capital Management's ten largest holdings make up 34% of its $932M portfolio in Q2 2019.
- Reynders McVeigh Capital Management opened 12 new positions and closed 9 in Q2 2019.
- Reynders McVeigh Capital Management's portfolio value rose 3.1% quarter-over-quarter to $932M.
Based on Reynders McVeigh Capital Management's 13F filing for Q2 2019, filed 6 Aug 2019.